Dr. Frank Mathias joined Rentschler Biopharma SE’s Supervisory Board in 2013 and was appointed Chief Executive Officer and Chairman of the Executive Board in April 2016.
Correction: To Remove Duplicate Tables.Achieved 168% Revenue Growth Year-Over-YearInitiated a Record Six System DeploymentsContracted Backlog… Read More
OXFORD, Mass., Jan. 30, 2023 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (Nasdaq: IPGP), the world… Read More
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.… Read More
Fourth annual Enhancing Your Impact continuing education conference addressed improving the care experience for individuals… Read More